Additional file 1: of Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

Le résumé fourni par la source

Solicited oculorespiratory syndrome–like symptoms within the 3-day post vaccination period in infants (6–35 months), children (3–17 years), and adults (18–49 years) (total vaccinated cohort). (PDF 378 kb)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.